Yifeng Sun

1.2k total citations · 1 hit paper
42 papers, 705 citations indexed

About

Yifeng Sun is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yifeng Sun has authored 42 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Surgery, 22 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Yifeng Sun's work include Esophageal Cancer Research and Treatment (20 papers), Gastric Cancer Management and Outcomes (16 papers) and Esophageal and GI Pathology (15 papers). Yifeng Sun is often cited by papers focused on Esophageal Cancer Research and Treatment (20 papers), Gastric Cancer Management and Outcomes (16 papers) and Esophageal and GI Pathology (15 papers). Yifeng Sun collaborates with scholars based in China, United States and France. Yifeng Sun's co-authors include Zhigang Li, Hezhong Chen, Xufeng Guo, Rong Hua, Bentong Yu, Yunqing Mei, Qiang Ji, Xisheng Wang, Jing Feng and Liangjie Chi and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Surgery.

In The Last Decade

Yifeng Sun

40 papers receiving 700 citations

Hit Papers

Multicenter, single-arm, phase II trial of camrelizumab a... 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yifeng Sun China 12 566 403 163 139 40 42 705
Jorge Lamelas United States 15 692 1.2× 494 1.2× 550 3.4× 100 0.7× 28 0.7× 19 899
Kozo Kataoka Japan 14 396 0.7× 415 1.0× 240 1.5× 31 0.2× 39 1.0× 76 681
Daisuke Nakamura Japan 12 351 0.6× 197 0.5× 59 0.4× 189 1.4× 8 0.2× 67 491
Sung Jin Oh South Korea 18 655 1.2× 1.1k 2.8× 259 1.6× 43 0.3× 42 1.1× 54 1.4k
Andrea Mabilia Italy 12 232 0.4× 252 0.6× 330 2.0× 54 0.4× 28 0.7× 16 567
Antonio Chiappa Italy 17 418 0.7× 341 0.8× 528 3.2× 85 0.6× 38 0.9× 48 891
Seung Hyun Kim South Korea 11 207 0.4× 145 0.4× 101 0.6× 48 0.3× 56 1.4× 28 448
Cécile de Chaisemartin France 16 664 1.2× 238 0.6× 683 4.2× 48 0.3× 51 1.3× 50 898
Tatsuaki Sumiyoshi Japan 16 441 0.8× 311 0.8× 388 2.4× 35 0.3× 15 0.4× 76 766

Countries citing papers authored by Yifeng Sun

Since Specialization
Citations

This map shows the geographic impact of Yifeng Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifeng Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifeng Sun more than expected).

Fields of papers citing papers by Yifeng Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yifeng Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifeng Sun. The network helps show where Yifeng Sun may publish in the future.

Co-authorship network of co-authors of Yifeng Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Yifeng Sun. A scholar is included among the top collaborators of Yifeng Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yifeng Sun. Yifeng Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gu, Haiyong, et al.. (2025). SPC25 upregulates CCND1 to promote the progression of esophageal squamous cell carcinoma by inhibiting MDM2-mediated E2F1 ubiquitination. Translational Oncology. 53. 102300–102300. 1 indexed citations
2.
Qi, Peng, et al.. (2024). Diagnostic Utility of a 90-Gene Expression Assay (Canhelp-Origin) for Patients with Metastatic Cancer with an Unclear or Unknown Diagnosis. Molecular Diagnosis & Therapy. 29(1). 81–89. 3 indexed citations
4.
Liu, Zhichao, Yang Yang, Bin Li, et al.. (2023). Salvage Esophagectomy After Definitive Chemoradiotherapy for Squamous Cell Esophageal Cancer: A Propensity Score Matching Study in a High‐Volume Center. World Journal of Surgery. 47(8). 2003–2012. 1 indexed citations
6.
Qi, Peng, Yifeng Sun, Xin Liu, et al.. (2022). Clinicopathological, molecular and prognostic characteristics of cancer of unknown primary in China: An analysis of 1420 cases. Cancer Medicine. 12(2). 1177–1188. 8 indexed citations
7.
Liu, Jun, Yang Yang, Zhichao Liu, et al.. (2022). Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma. Journal for ImmunoTherapy of Cancer. 10(3). e004291–e004291. 161 indexed citations breakdown →
8.
Guo, Xufeng, et al.. (2022). Robot-assisted versus thoracolaparoscopic oesophagectomy for locally advanced oesophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy. European Journal of Surgical Oncology. 49(4). 832–837. 4 indexed citations
9.
Wang, Qifeng, Fen Li, Yifeng Sun, et al.. (2021). Gene Expression Profiling for Differential Diagnosis of Liver Metastases: A Multicenter, Retrospective Cohort Study. Frontiers in Oncology. 11. 725988–725988. 7 indexed citations
10.
Zheng, Yu, Yifeng Sun, Huimin An, et al.. (2021). Gene expression profiling for the diagnosis of multiple primary malignant tumors. Cancer Cell International. 21(1). 47–47. 6 indexed citations
11.
Ye, Bo, Xiao‐Bin Zhang, Yuchen Su, et al.. (2020). The possibility of endoscopic treatment of cN0 submucosal esophageal cancer: results from a surgical cohort. Surgical Endoscopy. 35(2). 593–601. 6 indexed citations
12.
Yang, Yang, Bin Li, Rong Hua, et al.. (2020). Assessment of Quality Outcomes and Learning Curve for Robot-Assisted Minimally Invasive McKeown Esophagectomy. Annals of Surgical Oncology. 28(2). 676–684. 25 indexed citations
13.
Teng, Haohua, Yifeng Sun, Xufeng Guo, et al.. (2020). Near-Infrared Fluorescent Image-Guided Lymphatic Mapping in Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology. 27(10). 3799–3807. 6 indexed citations
14.
Ye, Qing, Qifeng Wang, Peng Qi, et al.. (2020). Development and Clinical Validation of a 90-Gene Expression Assay for Identifying Tumor Tissue Origin. Journal of Molecular Diagnostics. 22(9). 1139–1150. 17 indexed citations
15.
Hua, Rong, Yifeng Sun, Xufeng Guo, et al.. (2020). Risk Factors for Anastomotic Complications After Radical McKeown Esophagectomy. The Annals of Thoracic Surgery. 112(3). 944–951. 21 indexed citations
17.
Zheng, Yulong, Yongfeng Ding, Qifeng Wang, et al.. (2019). 90-gene signature assay for tissue origin diagnosis of brain metastases. Journal of Translational Medicine. 17(1). 331–331. 12 indexed citations
18.
Zhang, Xiaobin, Yang Yu, Yifeng Sun, et al.. (2019). Adjuvant therapy for pathological T3N0M0 esophageal squamous cell carcinoma. Journal of Thoracic Disease. 11(6). 2512–2522. 10 indexed citations
19.
Wang, Qifeng, Hualei Gan, Yifeng Sun, et al.. (2017). Identification and validation of a 44-gene expression signature for the classification of renal cell carcinomas. Journal of Experimental & Clinical Cancer Research. 36(1). 176–176. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026